跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 316 条关于
“FORTIFI-HN01”
全部
316
临床试验
274
药物
23
机构
8
资讯
11
去年
Bicara Launches Pivotal Phase 2/3 Trial of Novel Bifunctional Antibody for Advanced Head and Neck Cancer
去年
BridgeBio's BBP-418 Completes Enrollment in Phase 3 Trial for LGMD2I/R9
去年
Abcentra Initiates Phase 2b FORTIFY Trial for Novel Anti-Inflammatory Cardiovascular Therapy Orticumab
8个月前
Oxford Initiates European Enrollment for FORTIFY Trial Testing Orticumab in Post-Heart Attack Inflammation
上个月
Pliant Therapeutics Reports Strong Enrollment in FORTIFY Trial of PLN-101095, Appoints Oncology Veterans to Board
6个月前
Belief BioMed's Gene Therapy BBM-H901 Receives Approval in Macao for Hemophilia B Treatment
去年
89bio's Pegozafermin Advances in Phase 3 Trials for MASH and Severe Hypertriglyceridemia
去年
China Approves First Hemophilia B Gene Therapy: BBM-H901 Shows Promising Results in Single-Dose Treatment
7个月前
Japan Grants World-First Pharmaceutical Approval for Human Milk-Based Fortifier in Neonatal Care
去年
Merus Doses First Patient in Phase 3 Trial of Petosemtamab for Head and Neck Cancer
第 1 页,共 2 页
上一页
下一页